Abstract

Oral administration of active vitamin D is used as a standard medication for the treatment of hypoparathyroidism in our country. Although the dose required for the control of serum calcium level might be different dependent on the pathological type of hypoparathyroidism, the determination of maintenance dose and follow-up are performed by the measurements of serum and urinaly calcium levels. In the future, the clinical use of parathyroid hormone is expected for the treatment of hypoparathyroidism, since it is physiological.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call